In The Spotlight

Explore the latest information about different brands and therapies at Zydus Healthcare Limited.

24 May 2021

Zydus receives Emergency Use Approval from DCGI for the use of Pegylated Interferon alpha-2b, ‘Virafin’ in treating moderate COVID-19 infection in adults

Zydus gets approval for the emergency use of Pegylated interferon alpha-2b, ‘Virafin’ in the treatment of moderate C

Read More
03 Apr 2021

“VIVA India” – A Healthcare Professional Signature campaign sets a Limca Book of Records.

Zydus Medica’s VIVA India Campaign makes it to Limca Book of Records

Read More